London Health Sciences CentreLondon, ON
Disclosures:
283 - Measuring the Integration of Stereotactic Ablative Radiotherapy plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE): Long-Term Clinical Outcomes
Tuesday, October 1, 202412:45 PM – 12:55 PM ET
3439 - External Validation of an Artificial Intelligence Screening Tool for Interstitial Lung Disease in Patients Receiving Lung Stereotactic Ablative Radiotherapy
Tuesday, October 1, 20244:00 PM – 5:00 PM ET